Speech-Language Pathology for Globus Sensation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new treatment protocol for individuals experiencing globus pharyngeus, a condition characterized by a persistent sensation of a lump in the throat. The study tests whether a specific speech-language pathology approach can alleviate this sensation. Participants will engage with a speech-language pathologist through a series of six treatment steps. Adults evaluated at the Atrium Health Wake Forest Baptist Center for Voice and Swallowing Disorders who experience this lump sensation, but do not have a diagnosed swallowing disorder, may be suitable candidates. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance treatment options for globus pharyngeus.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this protocol is safe for addressing Globus pharyngeus?
Research has shown that speech-language therapy is generally safe, as it employs non-invasive methods, reducing the risk of complications. Although limited evidence exists on the effectiveness of these treatments for Globus pharyngeus (the sensation of a lump in the throat), the safety data remains reassuring.
A study from the Grabscheid Voice and Swallowing Center found that 76% of patients who received a similar treatment experienced improvement. This suggests that the treatment is not only safe but may also alleviate symptoms, though further research is needed to confirm its effectiveness.12345Why are researchers excited about this trial?
Researchers are excited about the SLP intervention protocol for globus sensation because it offers a non-invasive approach tailored by speech-language pathologists. Unlike typical treatments that might focus on medication or dietary changes, this protocol involves a hands-on, therapeutic technique specifically designed to address the sensation of a lump in the throat through targeted exercises and strategies. By engaging patients directly with a series of six structured components, it aims to provide relief by improving vocal and swallowing functions, representing a novel method that could complement or even replace standard treatments.
What evidence suggests that this SLP protocol is effective for Globus pharyngeus?
This trial will evaluate the effectiveness of a specific Speech-Language Pathologist (SLP) intervention protocol for treating globus pharyngeus (GP), a condition where individuals feel a lump in their throat. Studies have shown that speech-language therapy can benefit GP, with significant improvements reported. However, the quality of the evidence varies, and some studies highlight a lack of high-quality data. Speech-language therapists have successfully managed related issues, such as swallowing problems, by improving swallowing techniques, suggesting that similar methods could assist those with GP. While initial results are promising, more high-quality research is needed to confirm these benefits.12367
Who Is on the Research Team?
Lyndsay Madden, DO
Principal Investigator
Wake Forest University Health Sciences
Are You a Good Fit for This Trial?
Adults over 18 with a sensation of having a lump in their throat, known as Globus pharyngeus, can join this trial. They must be patients at the Atrium Health Wake Forest Baptist Center for Voice and Swallowing Disorders. Those with diagnosed swallowing disorders cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a standardized speech-language pathology intervention for Globus Pharyngeus
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Speech-language pathologist (SLP) protocol
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor